{
    "Case ID": "056139",
    "Different Crime": [
        {
            "Crime Name": "Patent Infringement",
            "Crime Type": "Economic_Crimes_or_Fraud-related_Offenses",
            "legal_basis": [
                "Patented Medicines (Notice of Compliance) Regulations",
                "Patent Act"
            ],
            "patent_validity": [
                "sufficiency",
                "utility",
                "obviousness"
            ],
            "expert_testimony": [
                "yes"
            ],
            "decision_outcome": [
                "application allowed",
                "Pharmascience's allegation of invalidity not justified"
            ],
            "cause_of_action": [
                "prohibition of regulatory approval for generic drug until patent expiration"
            ],
            "judicial_authority": [
                "judicial review under the NOC Regulations"
            ],
            "appeal_outcome": [
                "Pfizer succeeded in protecting its patent rights"
            ]
        }
    ]
}